IMVT
Immunovant Inc. Healthcare - Biotechnology Investor Relations →
Immunovant Inc. (IMVT) closed at $27.05 as of 2026-02-02, trading 27.3% above its 200-week moving average of $21.25. The stock moved further from the line this week, up from 23.0% last week. The 14-week RSI sits at 60, indicating neutral momentum.
Over the past 298 weeks of data, IMVT has crossed below its 200-week moving average 3 times. On average, these episodes lasted 45 weeks. Historically, investors who bought IMVT at the start of these episodes saw an average one-year return of +14.2%.
With a market cap of $5.5 billion, IMVT is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -69.3%. The stock trades at 5.6x book value.
Share count has increased 46.0% over three years, indicating dilution.
Over the past 5.8 years, a hypothetical investment of $100 in IMVT would have grown to $105, compared to $246 for the S&P 500. IMVT has returned 0.9% annualized vs 16.7% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $440,333,316.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: IMVT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IMVT Crosses Below the Line?
Across 3 historical episodes, buying IMVT when it crossed below its 200-week moving average produced an average return of +21.5% after 12 months (median +108.0%), compared to +23.0% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +1.0% vs +23.5% for the index.
Each line shows $100 invested at the moment IMVT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
IMVT has crossed below its 200-week MA 3 times with an average 1-year return of +14.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2021 | Dec 2022 | 96 | 80.1% | -75.4% | +21.8% |
| Mar 2023 | Apr 2023 | 7 | 9.8% | +103.8% | +74.0% |
| Mar 2025 | Oct 2025 | 31 | 25.8% | N/A | +47.3% |
| Average | 45 | — | +14.2% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02